Articles published by Allakos Inc.
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria
May 28, 2024
From Allakos Inc.
Via GlobeNewswire
Tickers
ALLK
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024
From Allakos Inc.
Via GlobeNewswire
Tickers
ALLK
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
February 26, 2024
From Allakos Inc.
Via GlobeNewswire
Tickers
ALLK
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
February 12, 2024
From Allakos Inc.
Via GlobeNewswire
Tickers
ALLK
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
Allakos Announces a Restructuring to Focus on Development of AK006
January 16, 2024
From Allakos Inc.
Via GlobeNewswire
Tickers
ALLK
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
Allakos Appoints Neil Graham to its Board of Directors
August 30, 2023
From Allakos Inc.
Via GlobeNewswire
Tickers
ALLK
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
March 06, 2023
From Allakos Inc.
Via GlobeNewswire
Tickers
ALLK
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
Allakos Announces Publication of AK006 Mechanism of Action Manuscript in Communications Biology
November 29, 2022
From Allakos Inc.
Via GlobeNewswire
Tickers
ALLK
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.